[12] Patent
[11] Patent No.:GC0011492  
[45] Date of Publishing the Grant of the Patent: 30/Nov /2020                76/2020  
Number of the Decision to Grant the Patent:2020/174765
Date of the Decision to Grant the Patent:11/Nov/2020

[21] Application No.:GC 2013-24163

[22] Filing Date:22/4/2013

[30] Priority:

[33] State [32] Priority date [31] Priority No.
US
US
23/4/2012
15/3/2013
636.938/61
792.089/61

[72] Inventors:1- Daiki KANEKO،2- Takakuni MATSUDA،3- Yusuke HOSHIKA

[73] Owner: OTSUKA PHARMACEUTICAL CO., LTD., 9, Kanda-Tsukasamachi 2-chome, Chiyoda-ku1018535 , Tokyo , Japan

[74] Agent: Abu-Gazaleh Intellectual Property L.L.C

  

 

  

[51]IPC:
Int. Cl.: A61K 31/496, 47/10, 47/32, 9/00, 9/06 (2006.01)

[56] Cited Documents:

-GB 864 100 A (PFIZER & CO C)29 March 1961
-WO 2012/026562 Al (OTSUKA PHARMA CO LTD[JP]; HIRAOKA SHOGO [JP] )1 March 2012
 
Examiner: PH. Abrar AlSaleem

[54] INJECTABLE PREPARATION, AND PREFILLED SYRINGE CONTAINING THE INJECTABLE PREPARATION
[57] Abstract: An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and further comprising a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by prefilling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 Pa•s or more in at least one point in the shear rate range of 0.01 to 0.02 s-1 and having a viscosity of 0.2 Pa•s or less in at least one point in the shear rate range of 900 to 1,000 s-1, as measured.
No. of claims: 28     No. of figures: 20


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.